4//SEC Filing
DERBYSHIRE ADAM C 4
Accession 0001209191-12-059669
CIK 0001009356other
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 4:38 PM ET
Size
11.5 KB
Accession
0001209191-12-059669
Insider Transaction Report
Form 4
DERBYSHIRE ADAM C
EVP Finance/CFO
Transactions
- Exercise/Conversion
Option to Buy Common Stock
2012-12-26−90,000→ 0 totalExercise: $8.00Exp: 2013-05-30→ Common Stock (90,000 underlying) - Sale
Common Stock
2012-12-26$41.44/sh−60,000$2,486,382→ 176,601 total - Exercise/Conversion
Common Stock
2012-12-26$8.00/sh+90,000$720,000→ 236,601 total
Holdings
- 30,000
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (30,000 underlying) - 20,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]This sale was pursuant to a Rule 10b5-1 Sales Plan dated November 19, 2012, which is intended to comply with Rule 10b5-1.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.11 to $42.02, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]Options are 100% vested.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeother
Related Parties
1- filerCIK 0001212669
Filing Metadata
- Form type
- 4
- Filed
- Dec 27, 7:00 PM ET
- Accepted
- Dec 28, 4:38 PM ET
- Size
- 11.5 KB